Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  NATIONAL STOCK EXCHANGE OF INDIA  >  Dr.Reddy's Laboratories Ltd    DRREDDY   INE089A01023

DR.REDDY'S LABORATORIES LTD (DRREDDY)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote National Stock Exchange O…
07/10/2018 07/11/2018 07/12/2018 07/13/2018 07/16/2018 Date
2318.95(c) 2298(c) 2352.3(c) 2315(c) 2083 Last
665 940 820 067 1 312 367 466 927 3 721 516 Volume
-0.48% -0.90% +2.36% -1.59% -10.02% Change
More quotes
Financials (INR)
Sales 2019 159 B
EBIT 2019 19 968 M
Net income 2019 15 624 M
Debt 2019 26 346 M
Yield 2019 0,92%
Sales 2020 179 B
EBIT 2020 26 651 M
Net income 2020 21 057 M
Debt 2020 20 176 M
Yield 2020 1,02%
P/E ratio 2019 24,16
P/E ratio 2020 18,38
EV / Sales2019 2,59x
EV / Sales2020 2,27x
Capitalization 385 B
More Financials
Company
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products.It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others.The Global Generics segment is consist of... 
More about the company
Surperformance© ratings of Dr.Reddy's Laboratories Lt
Trading Rating : Investor Rating :
More Ratings
Latest news on DR.REDDY'S LABORATORIES LT
11:23aIndivior's shares soar 33 percent after U.S. court blocks sale of rival gener..
RE
07/16DR.REDDY'S LABORATORIES LTD : Ex-dividend day for final dividend
FA
07/14DR REDDY LABORATORIES : announces its intent to appeal court decision in prelimi..
BU
07/14INDIVIOR : wins preliminary injunction against generic rival
RE
07/13DR REDDY LABORATORIES : announces the launch of Hydroxychloroquine Sulfate Table..
AQ
07/12INDIVIOR : share price dives in the wake of US market competition
AQ
07/11DR REDDY LABORATORIES : . Reddy's and UCB India enter into an agreement to co-pr..
AQ
07/11Indivior warning on anti-opioid drug competition sends shares tumbling
RE
07/11DR REDDY LABORATORIES : Announces the Launch of Hydroxychloroquine Sulfate Table..
BU
07/10DR REDDY LABORATORIES : `s gets exclusive right to distribute UCB`s epilepsy dru..
AQ
More news
Sector news : Pharmaceuticals - NEC
01:20pASTRAZENECA : Swedish Business Appoints New CEO
DJ
11:23aIndivior's shares soar 33 percent after U.S. court blocks sale of rival gener..
RE
08:16aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
07/13TEVA PHARMACEUTICAL INDUSTRIES : FDA Recalls Several Medicines That Contain Vals..
DJ
07/13NOVARTIS : Played Down Ties to Trump Lawyer Michael Cohen, Report Says
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
07/10Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)  
07/09$CRIS Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Fr.. 
07/06Curis $CRIS Sets New 1-Year Low at $1.57  
07/03Curis $CRIS Downgraded by ValuEngine  
06/30Head-To-Head Review: Curis $CRIS versus Heska $HSKA  
More tweets
Qtime:38
News from SeekingAlpha
07:18aDr. Reddy's down 8% premarket on injunction preventing U.S. launch of generic.. 
07/12Dr. Reddy's goes ex-dividend tomorrow 
06/22Court rules in favor of Ely Lilly in Alimta patent lawsuit 
06/18YOUR DAILY PHARMA SCOOP : Selecta Bio Reports Positive, Acceleron And Atara Move.. 
06/18Dr. Reddy's Lab defends right to launch buprenorphine and naloxone sublingual.. 
Chart DR.REDDY'S LABORATORIES LT
Duration : Period :
Dr.Reddy's Laboratories Lt Technical Analysis Chart | DRREDDY | INE089A01023 | 4-Traders
Technical analysis trends DR.REDDY'S LABORATORIES LT
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 40
Average target price 2 356  INR
Spread / Average Target 1,6%
EPS Revisions
Managers
NameTitle
Gunupati Venkateswara Prasad Co-Chairman, Chief Executive Officer & MD
Saumen Chakraborty President, CFO & Global Head-IT
Satish Kallam Reddy Co-Chairman
Erez Israeli Chief Operating Officer & Global Head-Generics
Kalpana Jaisingh Morparia Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
DR.REDDY'S LABORATORIES LTD-4.11%5 623
JOHNSON & JOHNSON-9.87%337 763
PFIZER3.62%219 534
NOVARTIS-3.93%201 464
ROCHE HOLDING LTD.-5.60%200 973
MERCK AND COMPANY11.76%169 193